Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
11.06
-0.27 (-2.38%)
At close: Aug 28, 2025, 4:00 PM
11.39
+0.33 (2.98%)
After-hours: Aug 28, 2025, 7:51 PM EDT
Aligos Therapeutics Employees
Aligos Therapeutics had 70 employees as of December 31, 2024. The number of employees increased by 4 or 6.06% compared to the previous year.
Employees
70
Change (1Y)
4
Growth (1Y)
6.06%
Revenue / Employee
$45,343
Profits / Employee
-$1,059,771
Market Cap
68.03M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 70 | 4 | 6.06% |
| Dec 31, 2023 | 66 | -17 | -20.48% |
| Dec 31, 2022 | 83 | -10 | -10.75% |
| Dec 31, 2021 | 93 | 19 | 25.68% |
| Dec 31, 2020 | 74 | 13 | 21.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ALGS News
- 8 days ago - Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Ramón Polo as Senior Vice President, Head of Global Regulatory Affairs - GlobeNewsWire
- 13 days ago - Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 15 days ago - Aligos Therapeutics Announces First Subject Dosed in the Phase 2 B-SUPREME Study of ALG-000184 in Subjects with Chronic HBV Infection - GlobeNewsWire
- 22 days ago - Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025 - GlobeNewsWire
- 2 months ago - Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC) - GlobeNewsWire
- 3 months ago - Aligos Therapeutics to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal - GlobeNewsWire